The COVID-19 pandemic has enabled consumers to perform rapid self-tests in the comfort of their homes, a convenient option that test makers like Abbott Laboratories, Becton Dickinson and Quidel are ...
After a bit of a rough patch, things are looking up for Quidel and its diagnostic offerings. The San Diego-based company snagged a CE mark for its Savanna molecular testing platform and the first ...
The QuickVue® At-Home COVID-19 Test employs the same Quidel lateral flow technology used for decades by healthcare professionals and features the same SARS CoV-2 rapid antigen test strip and reagent ...
SAN DIEGO--(BUSINESS WIRE)--Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, ...
More than a year after Quidel’s Lyra PCR assay for COVID-19 was granted emergency use authorization by the FDA, the agency has slapped a Class I label on a widespread recall of the tests. Quidel ...
The FDA granted emergency use authorization March 1 to Quidel’s at-home COVID-19 antigen test. The Quidel QuickVue At-Home COVID-19 Test is authorized for prescription use and doesn’t require test ...
San Diego’s Quidel Corp. boosted its fourth quarter sales forecast on Thursday after the omicron and delta variants sparked increased demand for its rapid at-home COVID-19 tests. The company, which ...
The government this week cleared the way for the Quidel Corporation (NASDAQ: QDEL), headquartered in Sorrento Valley, to offer its at-home COVID-19 test to the public. Quidel received the ...
Quidel is recalling its Lyra COVID-19 test because of a “significant” risk of false negative results in people infected with high amounts of the virus, the FDA said July 7. The test, which was granted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback